# Nebula Biocides

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nebula-biocides

- Industry: Software
- Headquarters: Germany
- Website: www.nebula-biocides.de
- Total disclosed funding: $1.9M
- Latest round: Seed (Sep 20, 2021)
- Investors on record: 2

## About

Based in Germany and founded in 2019, Nebula Biocides GmbH focuses on developing advanced disinfection solutions that meet stringent hygiene standards, offering effective biocidal agents for diverse applications in various industries.Nebula Biocides GmbH specializes in the creation of innovative biocidal agents that effectively eliminate pathogens in multiple settings. The company was founded in 2019 by Ansgar Maria Bleker, Ansgar Schmidt-Bleker, Jörn Winter, and Klaus-Dieter Weltmann, and is headquartered in Germany. In September 2021, Nebula Biocides GmbH raised EUR 1.6 million in Seed funding from investors including High-Tech Gründerfonds and Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern. This funding round brought the total amount raised to EUR 1.6 million, with a current company valuation of EUR 8.353 mn.Nebula Biocides GmbH specializes in advanced disinfection solutions, aiming to meet the highest standards of hygiene and safety. The company’s core product line includes concentrated and ready-to-use biocidal agents that effectively eliminate pathogens in various environments. These products are designed for diverse applications across healthcare facilities, food processing industries, and commercial spaces. Nebula Biocides GmbH markets its products primarily in European markets, including Germany, France, and the Nordic countries, addressing critical needs for sanitation and infection control.Nebula Biocides GmbH generates revenue through direct sales of its biocidal products to businesses and organizations, primarily using a B2B transaction model. The company engages with clients through a structured sales approach that may involve partnerships with distributors and wholesalers. Transactions typically encompass bulk orders for concentrated formulations and packaged ready-to-use products, catering to the varying needs of different sectors. Pricing structures are established based on product type and volume, allowing clients to select appropriate solutions for sanitation needs.In September 2021, Nebula Biocides GmbH raised EUR 1.6 million in Seed funding to support the launch of its highly effective disinfectant Sporosan. The company plans to expand its product offerings and enter new markets, focusing on areas with increasing demands for advanced disinfection solutions. Specific target regions for market expansion include additional European countries and potential entry into international markets by 2023.

## Funding rounds

- Seed, Sep 20, 2021, $1.9M — High-Tech Gruenderfonds, Mittelstandische Beteiligungsgesellschaft Mecklenburg-Vorpommern

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Mittelstandische Beteiligungsgesellschaft Mecklenburg-Vorpommern (https://capitalatlas.ai/funds/mittelstandische-beteiligungsgesellschaft-mecklenburg-vorpom) — Seed